CTSC:education Quantitative Imaging Biomarkers - Revision history

Valerie.humblet at 19:55, 28 October 2010

2010-10-28T19:55:36Z

Valerie.humblet at 18:35, 30 October 2009

2009-10-30T18:35:16Z

Valerie.humblet at 18:34, 30 October 2009

2009-10-30T18:34:15Z

Valerie.humblet at 17:42, 30 October 2009

2009-10-30T17:42:16Z

Valerie.humblet at 17:42, 30 October 2009

2009-10-30T17:42:06Z

Valerie.humblet: Created page with ' * Dr Kasia Macura, Johns Hopkins [[media: macura.pdf| Overview of imaging biomarkers and their use in clinical trials * Dr Randy Gollub, Harvard MGH [[media: | Generic principl…'

2009-10-30T17:40:08Z

Created page with ' * Dr Kasia Macura, Johns Hopkins [[media: macura.pdf| Overview of imaging biomarkers and their use in clinical trials * Dr Randy Gollub, Harvard MGH [[media: | Generic principl…'

New page

* Dr Kasia Macura, Johns Hopkins [[media: macura.pdf| Overview of imaging biomarkers and their use in clinical trials
* Dr Randy Gollub, Harvard MGH [[media: | Generic principles of image registration, segmentation, visualization]] (technical aspects)
* Dr Jeff Yap, Harvard DFCI [[media: Yap.pdf | Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials]] (e.g. RSNA QIBA)
** DCE-MRI (pre/post-therapy breast tumor perfusion)
** volumetric CT (e.g. lung tumor segmentation and volumetric measurement)
** FDG-PET/CT (pre/post-therapy whole-body imaging with SUV quantification)

← Older revision		Revision as of 19:55, 28 October 2010
Line 1:		Line 1:
−	Back to [[~~Collaboration~~:~~Harvard_CTSC~~\|~~Collaboration:Harvard_CTSC~~]] <br>	+	Back to [[CTSC:education\|Harvard Catalyst Imaging Working Group Education]] <br>

	== Quantitative imaging workshop ACRIN fall meeting, Arlington, VA, October 2009 ==		== Quantitative imaging workshop ACRIN fall meeting, Arlington, VA, October 2009 ==

@@ Line 1: / Line 1: @@
 Back to [[Collaboration:Harvard_CTSC|Collaboration:Harvard_CTSC]] <br>
-==
+== Quantitative imaging workshop ACRIN fall meeting, Arlington, VA, October 2009 ==
 * Dr Kasia Macura, Johns Hopkins [[media: macura.pdf| Overview of imaging biomarkers and their use in clinical trials]]

← Older revision		Revision as of 18:34, 30 October 2009
Line 1:		Line 1:
		+	Back to [[Collaboration:Harvard_CTSC\|Collaboration:Harvard_CTSC]] <br>
		+
		+	==
		+
	* Dr Kasia Macura, Johns Hopkins [[media: macura.pdf\| Overview of imaging biomarkers and their use in clinical trials]]		* Dr Kasia Macura, Johns Hopkins [[media: macura.pdf\| Overview of imaging biomarkers and their use in clinical trials]]
	* Dr Randy Gollub, Harvard MGH [[media: gollub.pdf\| Generic principles of image registration, segmentation, visualization]] (technical aspects)		* Dr Randy Gollub, Harvard MGH [[media: gollub.pdf\| Generic principles of image registration, segmentation, visualization]] (technical aspects)

@@ Line 1: / Line 1: @@
+* Dr Kasia Macura, Johns Hopkins [[media: macura.pdf| Overview of imaging biomarkers and their use in clinical trials]]
 * Dr Randy Gollub, Harvard MGH [[media: gollub.pdf| Generic principles of image registration, segmentation, visualization]] (technical aspects)
 * Dr Jeff Yap, Harvard DFCI [[media: Yap.pdf| Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials]] (e.g. RSNA QIBA)

@@ Line 1: / Line 1: @@
 * Dr Kasia Macura, Johns Hopkins [[media: macura.pdf| Overview of imaging biomarkers and their use in clinical trials
-* Dr Randy Gollub, Harvard MGH [[media: | Generic principles of image registration, segmentation, visualization]] (technical aspects)
+* Dr Randy Gollub, Harvard MGH [[media: gollub.pdf| Generic principles of image registration, segmentation, visualization]] (technical aspects)
-* Dr Jeff Yap, Harvard DFCI [[media: Yap.pdf | Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials]] (e.g. RSNA QIBA)
+* Dr Jeff Yap, Harvard DFCI [[media: Yap.pdf| Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials]] (e.g. RSNA QIBA)
 ** DCE-MRI (pre/post-therapy breast tumor perfusion)
 ** volumetric CT (e.g. lung tumor segmentation and volumetric measurement)
 ** FDG-PET/CT (pre/post-therapy whole-body imaging with SUV quantification)